GATA2 MUTATIONS ARE FREQUENT IN INTERMEDIATE RISK KARYOTYPE AML WITH BIALLELIC CEBPA MUTATIONS AND ARE ASSOCIATED WITH FAVORABLE PROGNOSIS

被引：0
|
作者：
Fasan, A. [1 ]
Eder, C. [1 ]
Haferlach, C. [1 ]
Kohlmann, A. [1 ]
Grossmann, V. [1 ]
Dicker, F. [1 ]
Kern, W. [1 ]
Haferlach, T. [1 ]
Schnittger, S. [1 ]
机构：
[1] MLL Munich Leukemia Lab, Munich, Germany
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0539
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [1] GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis
    Fasan, A.
    Eder, C.
    Haferlach, C.
    Grossmann, V.
    Kohlmann, A.
    Dicker, F.
    Kern, W.
    Haferlach, T.
    Schnittger, S.
    LEUKEMIA, 2013, 27 (02) : 482 - 485
  • [2] GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis
    A Fasan
    C Eder
    C Haferlach
    V Grossmann
    A Kohlmann
    F Dicker
    W Kern
    T Haferlach
    S Schnittger
    Leukemia, 2013, 27 : 482 - 485
  • [3] Allele-Specific Expression of GATA2 in AML with CEBPA Biallelic Mutations
    Mulet-Lazaro, Roger
    van Herk, Stanley
    Erpelinck-Verschueren, Claudia
    Sanders, Mathijs A.
    Bindels, Eric
    Valk, Peter
    Rehli, Michael
    Gebhard, Claudia
    Delwel, Ruud
    Wouters, B. J.
    BLOOD, 2019, 134
  • [4] THE INCIDENCE AND PROGNOSTIC SIGNIFICANCE OF GATA2 MUTATIONS IN AML PATIENTS WITH CEBPA MUTATIONS
    Green, C.
    Hills, R.
    Burnett, A.
    Linch, D.
    Gale, R.
    HAEMATOLOGICA, 2012, 97 : 217 - 217
  • [5] Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
    H-A Hou
    L-I Lin
    C-Y Chen
    H-F Tien
    British Journal of Cancer, 2009, 101 : 738 - 740
  • [6] Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'
    Hou, H-A
    Lin, L-I
    Chen, C-Y
    Tien, H-F
    BRITISH JOURNAL OF CANCER, 2009, 101 (04) : 738 - 740
  • [7] CEBPA Mutations Predict Favorable Prognosis in Pediatric AML
    Ho, Phoenix
    Alonzo, Todd A.
    Gerbing, Robert B.
    Pollard, Jessica A.
    Stirewalt, Derek
    HurwitZ, Craig Alan
    Heerema, Nyla A.
    Hirsch, Betsy
    Raimondi, Susana C.
    Lange, Beverly
    Franklin, Janet
    Radich, Jerald
    Meshinchi, Soheil
    BLOOD, 2008, 112 (11) : 58 - 58
  • [8] Exome sequencing identifies a unique association of GATA2 zinc finger 1 mutations with biallelic CEBPA mutations in acute myeloid leukemia (AML)
    Greif, P. A.
    Dufour, A.
    Konstandin, N.
    Ksienzyk, B.
    Zellmeier, E.
    Sturm, J.
    Tizazu, B.
    Herold, T.
    Benthaus, T.
    Yaghmaie, M.
    Doerge, P.
    Hopfner, K. P.
    Hauser, A.
    Graf, A.
    Krebs, S.
    Blum, H.
    Kakadia, P. M.
    Schneider, S.
    Hoster, E.
    Schneider, F.
    Stanulla, M.
    Braess, J.
    Sauerland, M. C.
    Berdel, W. E.
    Buechner, T.
    Woermann, B. J.
    Hiddemann, W.
    Spiekermann, K.
    Bohlander, S. K.
    ONKOLOGIE, 2012, 35 : 93 - 94
  • [9] GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
    Greif, Philipp A.
    Dufour, Annika
    Konstandin, Nikola P.
    Ksienzyk, Bianka
    Zellmeier, Evelyn
    Tizazu, Belay
    Sturm, Jutta
    Benthaus, Tobias
    Herold, Tobias
    Yaghmaie, Marjan
    Doerge, Petra
    Hopfner, Karl-Peter
    Hauser, Andreas
    Graf, Alexander
    Krebs, Stefan
    Blum, Helmut
    Kakadia, Purvi M.
    Schneider, Stephanie
    Hoster, Eva
    Schneider, Friederike
    Stanulla, Martin
    Braess, Jan
    Sauerland, Maria Cristina
    Berdel, Wolfgang E.
    Buechner, Thomas
    Woermann, Bernhard J.
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    Bohlander, Stefan K.
    BLOOD, 2012, 120 (02) : 395 - 403
  • [10] Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
    Pabst, T.
    Eyholzer, M.
    Fos, J.
    Mueller, B. U.
    BRITISH JOURNAL OF CANCER, 2009, 100 (08) : 1343 - 1346
12345